External Stakeholders: Healthcare professionals (HCPs), including physicians, pharmacists, and clinical investigators; Key Opinion Leaders (KOLs) and scientific experts in assigned therapeutic areas; Medical societies, professional associations, and academic institutions; Regulatory authorities, payors, and government health agencies; Patient advocacy groups and relevant non-governmental organizations; Contributors to national formularies.
Internal Stakeholders: Country Medical Lead (CML), supporting external engagement and strategic initiatives; Cluster Scientific Experts; Cross-functional teams: Access & Value, Regulatory, Clinical Operations, Commercial, and Brand Teams; Cluster medical leadership and international medical colleagues
The MAS may contribute to budget planning and oversight for medical initiatives, scientific events, and evidence generation activities, working collaboratively with the Country Medical Lead and cross-functional teams to ensure resources are used efficiently to maximize patient and business impact.
Work Location Assignment: Remote - Field Based